Palatability (Taste) of Oral Formulations of Bosutinib
Status:
Completed
Trial end date:
2019-01-14
Target enrollment:
Participant gender:
Summary
Healthy Adult Volunteer Taste Study of Oral Formulations of Bosutinib for Pediatric Use. This
will be a single-blind, randomized, multiple-period (dosing over 4 days) study in healthy
male and/or female participants. Approximately 8 participants will assess the sensory
attributes of different powder for oral suspension (POS) formulations.